However, as mentioned above, Davidson et al. [87] showed that the levels of p-TrkA were associated with tumor progression to effusion in metastatic breast carcinoma, thus correlating the dysregulation of p-TrkA with poor prognostic outcome in a more uniform cohort of 39 patients. The gene discussed is NTRK1; the disease is neoplasm.